AKBAAKEBIA THERAPEUTICS INC
CUSIP 00972D105 · common stock
No tracked investor reported shares of AKEBIA THERAPEUTICS INC (AKBA) for Q3 2026. Joel Greenblatt sold out of its position this quarter.
Holders · Q3 2026
0
New holders
0
Value held
$0
Quarter-end price (est.)
—
Investors holding AKBA · Q3 2026
No tracked investor reported shares this quarter.
Sold out this quarter
| Investor | Prior weight | Prior shares | Prior value | Change |
|---|---|---|---|---|
| Joel Greenblatt | 0.00% | 36,053 | $41.1K | EXIT |
History
| Quarter | Holders | New | Sold out | Value held | Quarter-end price (est.) |
|---|---|---|---|---|---|
| Q3 2026 | 0 | 0 | 1 | $0 | — |
| Q2 2026 | 1 | 0 | 1 | $41.1K | $1.14 |
| Q1 2026 | 2 | 1 | 0 | $77.2K | $1.39 |
| Q4 2025 | 1 | 0 | 0 | $25.7K | $1.61 |
| Q3 2020 | 0 | 0 | 1 | $0 | — |
| Q2 2020 | 1 | 0 | 0 | $203.7M | $13.58 |
| Q1 2020 | 1 | 0 | 0 | $132.9M | $7.58 |
| Q4 2019 | 1 | 0 | 0 | $123.7M | $6.32 |
| Q3 2019 | 1 | 0 | 0 | $95.9M | $3.92 |
| Q2 2019 | 1 | 0 | 0 | $118.4M | $4.84 |
| Q1 2019 | 1 | 0 | 0 | $200.4M | $8.19 |
| Q4 2018 | 1 | 1 | 0 | $135.3M | $5.53 |